Lumenis M22 skin surface treatment system - HSA Registration DE0006715
Access comprehensive regulatory information for Lumenis M22 skin surface treatment system in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0006715 and owned by Lumenis Ltd. The device was registered on May 06, 2011.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Lumenis M22 system has connection capability with the following available treatment modules, for multi-application treatment options. All modules are designed for aesthetic and dermatological skin procedure application, as follows: The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200nm (with different filters) is indicated for warts and mild to moderate inflammatory acne (acne vulgaris). For the treatment of Evaporative Dry Eye Disease, also known as dry eye syndrome or lipid tear deficiency, due to Meibomian Gland Dysfunction. The Multi-Spot Nd:YAG Laser, with a wavelength of 1064 nm is indicated for coagulation and hemostasis of soft tissue. The ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for use in dermatological procedures requiring coagulation of soft tissue.